No Data
No Data
Healios K.K Gets FDA Nod for Global ARDS Phase 3 Trial; Shares Up 10%
Volume change rate ranking (10 o'clock) - Zain, Helios, etc. are ranked.
In the volume change rate ranking, you can understand the interests of market participants such as trends in speculation by comparing the average volume of the past 5 days with the volume on the day of distribution. Top volume change rate [September 10, 10:32 AM] (comparison with average volume of the past 5 days) Stock code Stock name Volume Average volume of the past 5 days Volume change rate Stock price change rate <2247> iF500H no 12831 47427.793 266.8% 0.0116
The Tokyo Stock Exchange Growth Market Index showed a small rebound, demonstrating relative strength on the first day.
Tokyo Stock Exchange Growth Market Index 823.97 +1.23 / Volume 0.1 billion50.75 million shares / Trading value 92.6 billion yen Tokyo Stock Exchange Growth Market 250 Index 645.21 +1.33 / Volume 91.85 million shares / Trading value 72.9 billion yen In today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index showed a small rebound. The number of advancing issues was 243, declining issues was 316, unchanged was 28. In the U.S. market on the 6th, the Dow Jones Industrial Average fell by 410.34 points to 40345.41.
Jefferies Upgrades Healios to Buy From Hold, Adjusts Price Target to 320 Yen From 140 Yen
Volume change rate ranking (14:00s) - Tsubota Lab, Sairen, etc. rank in.
In the volume change rate ranking, you can understand the market participants' interests, such as trends in trading, by comparing the average volume for the past 5 days with the volume on the delivery day. ■ Volume Change Rate Top [As of September 9, 14:32] (Comparison of average volume for the past 5 days) Stock Code Stock Name Volume 5-day Average Volume Volume Change Rate Stock Price Change Rate <4890> Tsubota Lab 2356600 23350.58 364.63% 0.1075
Healios KK Advances Global Phase 3 ARDS Trial
No Data
No Data